Figure 1.
Study flowchart summarizing patient recruitment, sample selection for assay cohorts, diagnosis and assay QC steps including reasons for exclusion from the final analysis, and disease group memberships. AEC, asbestos-exposed control; MPM, Malignant pleural mesothelioma; QC, quality control; SPM, suspected pleural malignancy.